- Published on
Infectious Disease and Microbiology – Anorectal Infections
Anorectal infections involve the anus and rectum, the distal portion of the large intestine. These infections range from sexually transmitted diseases and perianal abscesses to life-threatening necrotizing infections such as Fournier’s gangrene, which affects the external genitalia and perineum. In organ transplant recipients, the prevalence of external anogenital lesions ranges from 1.5% to 2.3%, with women more commonly affected. Most lesions are due to anogenital warts, followed by bowenoid papulosis, giant condyloma, and in situ carcinoma.
Risk factors for severe anorectal infections such as Fournier’s gangrene include prior urinary tract infections, urologic instrumentation, and chronic colorectal disease. Many affected patients have comorbid conditions such as diabetes mellitus, alcoholism, or intravenous drug use, which impair host immune defenses. In immunocompromised individuals, perianal abscesses and fistulas must be promptly identified and treated with adequate drainage or fistulectomy to prevent progression to necrotizing infection or metastatic abscess formation.
Pathophysiology varies by cause. Primary anal or rectal infections commonly occur after receptive anorectal intercourse, particularly among men who have sex with men and in women. Rectal infection with Chlamydia trachomatis (including lymphogranuloma venereum strains) may result from direct inoculation or contiguous spread from genital secretions. Herpes simplex virus (HSV-1 and HSV-2) can cause symptomatic or asymptomatic proctitis and perianal disease; viral shedding may occur even in individuals without a history of rectal intercourse. Perianal warts caused by human papillomavirus (HPV) are common in both men who have sex with men and heterosexual men. Perirectal abscesses may arise from extension of infection related to diverticulitis, Crohn’s disease, ulcerative colitis, or previous surgery. Fournier’s gangrene is typically polymicrobial, involving mixed aerobic and anaerobic organisms.
Common infectious causes include bacterial and parasitic pathogens as well as sexually transmitted infections. Among men who have sex with men, frequent causes include anorectal gonorrhea, HSV, syphilis, Chlamydia trachomatis, and enteric pathogens such as Giardia lamblia, Entamoeba histolytica, and Campylobacter species. In patients with HIV infection, perirectal ulcers due to HSV reactivation are common, along with condyloma acuminatum, Kaposi’s sarcoma, and intraepithelial neoplasia. Diabetes mellitus (type I and II) is commonly associated with severe soft tissue infections in this region.
Clinical manifestations depend on the etiology. HSV proctitis typically presents with anorectal pain, discharge, tenesmus, and constipation. Anogenital warts appear as cauliflower-like condyloma acuminata on moist surfaces, keratotic papules on dry surfaces, or flat subclinical lesions on mucosal or cutaneous areas. Fournier’s gangrene presents with severe pain that may be disproportionate to physical findings, massive swelling of the scrotum and penis, erythema, bullae, and progression to gangrene extending into the perineum or abdominal wall. Systemic toxicity may develop rapidly.
Diagnosis includes laboratory and imaging studies. Anorectal swabs with PCR testing are useful for detecting C. trachomatis. In HSV infection, sigmoidoscopy may reveal ulcerative lesions in the distal rectum, and biopsy may show mucosal ulceration with multinucleated cells containing viral inclusions. Laboratory tests such as complete blood count, inflammatory markers, metabolic panels, creatine phosphokinase, glucose levels, and arterial blood gases are important in severely ill patients. CT or MRI imaging helps assess abscess formation or soft tissue involvement. Differential diagnosis includes condylomata lata of secondary syphilis, molluscum contagiosum, neoplasms, and donovanosis, particularly in endemic regions.
Management depends on the specific infection. Cryotherapy may be effective for genital warts that do not respond to topical therapy, though perianal warts may be more resistant. Perianal abscesses require prompt drainage and antibiotics. Fournier’s gangrene requires immediate and aggressive surgical exploration with debridement of necrotic tissue, reduction of compartment pressure, and collection of cultures. Broad-spectrum intravenous antibiotics covering aerobic and anaerobic organisms are essential; regimens may include clindamycin combined with ampicillin or ampicillin–sulbactam plus gentamicin. Hyperbaric oxygen therapy may be beneficial in selected cases, particularly with clostridial involvement. Patients often require intensive care management.
Follow-up is important, particularly in patients with anal warts and HIV infection, as both are independent risk factors for anal cytologic abnormalities and precancerous lesions. High-risk groups, including men with HPV infection, intravenous drug users, and organ transplant recipients, may benefit from anal cytology screening. Complications include secondary infection of warts, bleeding, mechanical obstruction, perianal sepsis in immunocompromised individuals, and septicemia in Fournier’s gangrene, which carries a mortality rate ranging from 22% to 66%.
Anorectal infections involve the anus and rectum, the distal portion of the large intestine. These infections range from sexually transmitted diseases and perianal abscesses to life-threatening necrotizing infections such as Fournier’s gangrene, which affects the external genitalia and perineum. In organ transplant recipients, the prevalence of external anogenital lesions ranges from 1.5% to 2.3%, with women more commonly affected. Most lesions are due to anogenital warts, followed by bowenoid papulosis, giant condyloma, and in situ carcinoma.
Risk factors for severe anorectal infections such as Fournier’s gangrene include prior urinary tract infections, urologic instrumentation, and chronic colorectal disease. Many affected patients have comorbid conditions such as diabetes mellitus, alcoholism, or intravenous drug use, which impair host immune defenses. In immunocompromised individuals, perianal abscesses and fistulas must be promptly identified and treated with adequate drainage or fistulectomy to prevent progression to necrotizing infection or metastatic abscess formation.
Pathophysiology varies by cause. Primary anal or rectal infections commonly occur after receptive anorectal intercourse, particularly among men who have sex with men and in women. Rectal infection with Chlamydia trachomatis (including lymphogranuloma venereum strains) may result from direct inoculation or contiguous spread from genital secretions. Herpes simplex virus (HSV-1 and HSV-2) can cause symptomatic or asymptomatic proctitis and perianal disease; viral shedding may occur even in individuals without a history of rectal intercourse. Perianal warts caused by human papillomavirus (HPV) are common in both men who have sex with men and heterosexual men. Perirectal abscesses may arise from extension of infection related to diverticulitis, Crohn’s disease, ulcerative colitis, or previous surgery. Fournier’s gangrene is typically polymicrobial, involving mixed aerobic and anaerobic organisms.
Common infectious causes include bacterial and parasitic pathogens as well as sexually transmitted infections. Among men who have sex with men, frequent causes include anorectal gonorrhea, HSV, syphilis, Chlamydia trachomatis, and enteric pathogens such as Giardia lamblia, Entamoeba histolytica, and Campylobacter species. In patients with HIV infection, perirectal ulcers due to HSV reactivation are common, along with condyloma acuminatum, Kaposi’s sarcoma, and intraepithelial neoplasia. Diabetes mellitus (type I and II) is commonly associated with severe soft tissue infections in this region.
Clinical manifestations depend on the etiology. HSV proctitis typically presents with anorectal pain, discharge, tenesmus, and constipation. Anogenital warts appear as cauliflower-like condyloma acuminata on moist surfaces, keratotic papules on dry surfaces, or flat subclinical lesions on mucosal or cutaneous areas. Fournier’s gangrene presents with severe pain that may be disproportionate to physical findings, massive swelling of the scrotum and penis, erythema, bullae, and progression to gangrene extending into the perineum or abdominal wall. Systemic toxicity may develop rapidly.
Diagnosis includes laboratory and imaging studies. Anorectal swabs with PCR testing are useful for detecting C. trachomatis. In HSV infection, sigmoidoscopy may reveal ulcerative lesions in the distal rectum, and biopsy may show mucosal ulceration with multinucleated cells containing viral inclusions. Laboratory tests such as complete blood count, inflammatory markers, metabolic panels, creatine phosphokinase, glucose levels, and arterial blood gases are important in severely ill patients. CT or MRI imaging helps assess abscess formation or soft tissue involvement. Differential diagnosis includes condylomata lata of secondary syphilis, molluscum contagiosum, neoplasms, and donovanosis, particularly in endemic regions.
Management depends on the specific infection. Cryotherapy may be effective for genital warts that do not respond to topical therapy, though perianal warts may be more resistant. Perianal abscesses require prompt drainage and antibiotics. Fournier’s gangrene requires immediate and aggressive surgical exploration with debridement of necrotic tissue, reduction of compartment pressure, and collection of cultures. Broad-spectrum intravenous antibiotics covering aerobic and anaerobic organisms are essential; regimens may include clindamycin combined with ampicillin or ampicillin–sulbactam plus gentamicin. Hyperbaric oxygen therapy may be beneficial in selected cases, particularly with clostridial involvement. Patients often require intensive care management.
Follow-up is important, particularly in patients with anal warts and HIV infection, as both are independent risk factors for anal cytologic abnormalities and precancerous lesions. High-risk groups, including men with HPV infection, intravenous drug users, and organ transplant recipients, may benefit from anal cytology screening. Complications include secondary infection of warts, bleeding, mechanical obstruction, perianal sepsis in immunocompromised individuals, and septicemia in Fournier’s gangrene, which carries a mortality rate ranging from 22% to 66%.
- Published on
Infectious Disease and Microbiology – Anaerobic Infections
Anaerobic infections are caused by bacteria that require reduced oxygen tension for growth. Most anaerobes involved in human disease are aerotolerant, meaning they can survive but not replicate in oxygenated environments for up to 72 hours. These organisms normally colonize mucosal surfaces, including the oral cavity, gastrointestinal tract, and female genital tract, and commonly cause infections that originate from these sites. Anaerobes account for up to 10% of clinically significant bloodstream infections, although precise incidence data for other infection sites are limited.
Risk factors include disruption of mucosal barriers due to malignancy, chemotherapy, radiation, neutropenia, graft-versus-host disease, surgery, trauma, inflammatory bowel disease, diverticulitis, or appendicitis. Poor dental hygiene predisposes to oral and pulmonary infections. Conditions such as altered mental status, impaired swallowing, or depressed gag reflex increase the risk of aspiration and subsequent anaerobic lung infections. Preventive strategies include perioperative antimicrobial prophylaxis, bowel preparation when indicated, maintenance of good dental hygiene, and aspiration precautions.
Pathogenesis involves translocation of resident anaerobic flora into normally sterile tissues following mucosal disruption. Aspiration introduces oral anaerobes into the lungs. In polymicrobial infections, aerobic bacteria may reduce the oxidation–reduction potential, facilitating anaerobic growth. Virulence factors contribute to abscess formation and immune evasion; for example, Bacteroides fragilis produces capsular polysaccharide, Prevotella species produce IgA proteases, Porphyromonas gingivalis produces proteases, and Fusobacterium necrophorum produces leukotoxin and endotoxin.
The most common anaerobic Gram-negative bacillus is Bacteroides fragilis. Other important Gram-negative genera include Fusobacterium, Prevotella, and Porphyromonas. Among Gram-positive organisms, Peptostreptococcus species are common cocci, and Clostridium species are major Gram-positive rods associated with disease.
Anaerobes are implicated in a wide range of infections. Oral and dental infections include pulpitis, dental abscesses, perimandibular space infections, gingivitis, periodontitis, and periodontal abscesses. Severe head and neck infections include Vincent’s stomatitis (trench mouth), Ludwig’s angina involving sublingual and submandibular spaces, and Lemierre syndrome, characterized by F. necrophorum infection with internal jugular vein thrombophlebitis and septic pulmonary emboli. Pleuropulmonary manifestations include aspiration pneumonia, necrotizing pneumonia, lung abscess, and empyema. Intraabdominal infections include peritonitis, abscesses, and neutropenic colitis (typhlitis). Female genital tract infections include pelvic inflammatory disease, tubo-ovarian abscess, septic abortion, endometritis, and bacterial vaginosis. Central nervous system involvement may present as brain abscess, epidural abscess, subdural empyema, or rarely anaerobic meningitis. Skin and soft tissue infections include necrotizing fasciitis, gas gangrene, bite wounds, diabetic foot infections, and infected surgical wounds. Anaerobic bacteremia often arises secondary to intraabdominal, genital tract, respiratory, or soft tissue infections, with B. fragilis being the most common isolate.
Clinical features depend on the site of infection. Foul odor, abscess formation, tissue necrosis, and infection adjacent to mucosal surfaces suggest anaerobic involvement. Gas in tissues with crepitus indicates infection by gas-forming organisms. Vincent’s stomatitis presents with tender bleeding gums, halitosis, fever, and lymphadenopathy. Ludwig’s angina causes submandibular pain, trismus, tongue displacement, and potential airway compromise. Lemierre syndrome follows oropharyngeal infection with high fever, neck tenderness, and pulmonary metastases. Anaerobic lung abscess presents with chronic malaise, foul-smelling sputum, fever, and anemia. Typhlitis presents with neutropenia, right lower quadrant pain, fever, and diarrhea. Lack of response to antibiotics without anaerobic coverage should raise suspicion.
Diagnosis is challenging because anaerobes are difficult to culture. Proper specimen collection is critical: aspirated fluids or tissue samples are preferred over swabs, air must be excluded from syringes, and specimens require anaerobic transport media with rapid processing. Gram staining is essential; the presence of organisms on Gram stain without growth in culture suggests anaerobes. Imaging may reveal air–fluid levels, cavitation, or gas in tissues. CT or MRI helps define extent of disease. Image-guided aspiration or biopsy may be required. Anaerobic lung abscess must be differentiated from mycobacterial infection.
Management requires both surgical and antimicrobial therapy. Drainage, debridement, or resection is often essential. Empiric antibiotics should provide coverage for both aerobic and anaerobic organisms due to frequent polymicrobial infection. Infections below the diaphragm require specific coverage for B. fragilis, which is resistant to penicillin. Effective agents include carbapenems, beta-lactam/beta-lactamase inhibitor combinations, and metronidazole, although metronidazole lacks activity against Actinomyces, Propionibacterium, Peptostreptococcus, and microaerophilic streptococci. Resistance among B. fragilis to clindamycin, cephamycins, and fluoroquinolones has increased. Susceptibility testing is recommended in cases requiring prolonged therapy, such as brain abscess or osteomyelitis.
Close follow-up is necessary to ensure adequate abscess drainage and clinical response. Repeat imaging and sampling may be needed if there is no improvement. Monitoring for antimicrobial toxicity is important. Untreated infections may spread contiguously, leading to serious complications.
Anaerobic infections are caused by bacteria that require reduced oxygen tension for growth. Most anaerobes involved in human disease are aerotolerant, meaning they can survive but not replicate in oxygenated environments for up to 72 hours. These organisms normally colonize mucosal surfaces, including the oral cavity, gastrointestinal tract, and female genital tract, and commonly cause infections that originate from these sites. Anaerobes account for up to 10% of clinically significant bloodstream infections, although precise incidence data for other infection sites are limited.
Risk factors include disruption of mucosal barriers due to malignancy, chemotherapy, radiation, neutropenia, graft-versus-host disease, surgery, trauma, inflammatory bowel disease, diverticulitis, or appendicitis. Poor dental hygiene predisposes to oral and pulmonary infections. Conditions such as altered mental status, impaired swallowing, or depressed gag reflex increase the risk of aspiration and subsequent anaerobic lung infections. Preventive strategies include perioperative antimicrobial prophylaxis, bowel preparation when indicated, maintenance of good dental hygiene, and aspiration precautions.
Pathogenesis involves translocation of resident anaerobic flora into normally sterile tissues following mucosal disruption. Aspiration introduces oral anaerobes into the lungs. In polymicrobial infections, aerobic bacteria may reduce the oxidation–reduction potential, facilitating anaerobic growth. Virulence factors contribute to abscess formation and immune evasion; for example, Bacteroides fragilis produces capsular polysaccharide, Prevotella species produce IgA proteases, Porphyromonas gingivalis produces proteases, and Fusobacterium necrophorum produces leukotoxin and endotoxin.
The most common anaerobic Gram-negative bacillus is Bacteroides fragilis. Other important Gram-negative genera include Fusobacterium, Prevotella, and Porphyromonas. Among Gram-positive organisms, Peptostreptococcus species are common cocci, and Clostridium species are major Gram-positive rods associated with disease.
Anaerobes are implicated in a wide range of infections. Oral and dental infections include pulpitis, dental abscesses, perimandibular space infections, gingivitis, periodontitis, and periodontal abscesses. Severe head and neck infections include Vincent’s stomatitis (trench mouth), Ludwig’s angina involving sublingual and submandibular spaces, and Lemierre syndrome, characterized by F. necrophorum infection with internal jugular vein thrombophlebitis and septic pulmonary emboli. Pleuropulmonary manifestations include aspiration pneumonia, necrotizing pneumonia, lung abscess, and empyema. Intraabdominal infections include peritonitis, abscesses, and neutropenic colitis (typhlitis). Female genital tract infections include pelvic inflammatory disease, tubo-ovarian abscess, septic abortion, endometritis, and bacterial vaginosis. Central nervous system involvement may present as brain abscess, epidural abscess, subdural empyema, or rarely anaerobic meningitis. Skin and soft tissue infections include necrotizing fasciitis, gas gangrene, bite wounds, diabetic foot infections, and infected surgical wounds. Anaerobic bacteremia often arises secondary to intraabdominal, genital tract, respiratory, or soft tissue infections, with B. fragilis being the most common isolate.
Clinical features depend on the site of infection. Foul odor, abscess formation, tissue necrosis, and infection adjacent to mucosal surfaces suggest anaerobic involvement. Gas in tissues with crepitus indicates infection by gas-forming organisms. Vincent’s stomatitis presents with tender bleeding gums, halitosis, fever, and lymphadenopathy. Ludwig’s angina causes submandibular pain, trismus, tongue displacement, and potential airway compromise. Lemierre syndrome follows oropharyngeal infection with high fever, neck tenderness, and pulmonary metastases. Anaerobic lung abscess presents with chronic malaise, foul-smelling sputum, fever, and anemia. Typhlitis presents with neutropenia, right lower quadrant pain, fever, and diarrhea. Lack of response to antibiotics without anaerobic coverage should raise suspicion.
Diagnosis is challenging because anaerobes are difficult to culture. Proper specimen collection is critical: aspirated fluids or tissue samples are preferred over swabs, air must be excluded from syringes, and specimens require anaerobic transport media with rapid processing. Gram staining is essential; the presence of organisms on Gram stain without growth in culture suggests anaerobes. Imaging may reveal air–fluid levels, cavitation, or gas in tissues. CT or MRI helps define extent of disease. Image-guided aspiration or biopsy may be required. Anaerobic lung abscess must be differentiated from mycobacterial infection.
Management requires both surgical and antimicrobial therapy. Drainage, debridement, or resection is often essential. Empiric antibiotics should provide coverage for both aerobic and anaerobic organisms due to frequent polymicrobial infection. Infections below the diaphragm require specific coverage for B. fragilis, which is resistant to penicillin. Effective agents include carbapenems, beta-lactam/beta-lactamase inhibitor combinations, and metronidazole, although metronidazole lacks activity against Actinomyces, Propionibacterium, Peptostreptococcus, and microaerophilic streptococci. Resistance among B. fragilis to clindamycin, cephamycins, and fluoroquinolones has increased. Susceptibility testing is recommended in cases requiring prolonged therapy, such as brain abscess or osteomyelitis.
Close follow-up is necessary to ensure adequate abscess drainage and clinical response. Repeat imaging and sampling may be needed if there is no improvement. Monitoring for antimicrobial toxicity is important. Untreated infections may spread contiguously, leading to serious complications.
- Published on
Infectious Disease and Microbiology – Amebiasis
Amebiasis is a protozoal infection caused by Entamoeba histolytica. Infection may result in asymptomatic colonization, diarrhea, colitis, or invasive extra-intestinal disease, most commonly liver abscess. Although approximately 10% of the global population is estimated to be infected, symptomatic disease develops in fewer than 10% of infected individuals, and only a small proportion of those with intestinal infection progress to invasive disease.
Prevalence varies geographically, ranging from less than 5% in developed countries to 20–30% in tropical regions. In the United States, prevalence is estimated at under 4%. Infection occurs at all ages and affects both sexes equally. In endemic areas, risk factors include low socioeconomic status, poor sanitation, and overcrowding. In low-prevalence regions, infection is more common among immigrants and travelers from endemic areas, institutionalized individuals, and men who have sex with men. Severe disease is more likely in neonates, pregnant women, malnourished individuals, and those receiving corticosteroid therapy.
Humans are the only reservoir. Transmission occurs via the fecal–oral route, typically through ingestion of contaminated water or food. Chlorination does not reliably destroy cysts; boiling water is required for effective decontamination. Proper washing of vegetables with potable water or treatment with detergent and vinegar reduces risk. The organism exists in two forms: the trophozoite, which may contain ingested erythrocytes, and the quadrinucleate cyst, which is the infective form. After ingestion, excystation occurs in the small intestine, releasing trophozoites that colonize the colon. Most infected individuals remain asymptomatic cyst passers. In invasive disease, trophozoites penetrate the colonic mucosa, producing characteristic flask-shaped ulcers. Cysts can survive for months in moist environments.
Several Entamoeba species infect humans, but E. histolytica is the primary pathogenic species. Morphologically similar nonpathogenic species include Entamoeba dispar, Entamoeba moshkovskii, Entamoeba hartmanni, and Entamoeba coli.
Clinical manifestations depend on the extent of invasion. Symptoms of intestinal disease usually develop within four weeks of cyst ingestion. Asymptomatic infection is common. Noninvasive disease presents with mild diarrhea. Amebic colitis or dysentery causes crampy abdominal pain, bloody and mucoid diarrhea, rectal bleeding (especially in children), fever in about one-third of patients, weight loss, and anorexia. Extra-intestinal disease most frequently involves the liver, with abscess formation developing approximately three months after infection. Patients present with fever and right upper quadrant pain, and half may not recall prior colitis. Abscess rupture can cause peritonitis, empyema, or pleural involvement. Cerebral amebiasis is rare but presents with headache, nausea, vomiting, and altered mental status.
On examination, colitis may produce diffuse abdominal tenderness, distention, and signs of peritonitis in severe cases. Liver abscess is associated with right upper quadrant tenderness, hepatomegaly, and rarely jaundice.
Diagnosis relies on stool microscopy, antigen detection, serology, imaging, and sometimes biopsy. Stool ova and parasite examination may reveal trophozoites with ingested red blood cells. Multiple stool samples increase sensitivity. Fecal antigen detection by ELISA is more sensitive than microscopy but less sensitive than PCR. Serology is useful in invasive disease and liver abscess, though antibodies may persist for years and are less helpful in endemic regions. Leukocytosis without eosinophilia is common in invasive disease, and liver abscess may show elevated alkaline phosphatase and mild transaminase elevations. Imaging with ultrasound, CT, or MRI typically demonstrates a right-lobe liver abscess. Colonoscopy may reveal friable mucosa and flask-shaped ulcers. Aspiration of a liver abscess yields characteristic brown, odorless “anchovy paste” material, although organisms are often not recovered from the fluid itself.
Differential diagnosis includes ulcerative colitis, Crohn’s disease, colorectal carcinoma, diverticulitis, abdominal abscess, pyogenic liver abscess, hepatoma, echinococcal cyst, and irritable bowel syndrome.
Treatment depends on clinical presentation. Asymptomatic luminal infection should be treated to prevent invasive disease, typically with paromomycin for seven days, or alternatives such as diloxanide furoate or iodoquinol. Amebic colitis requires metronidazole or tinidazole followed by a luminal agent such as paromomycin or iodoquinol to eradicate cysts. Amebic liver abscess is treated with metronidazole followed by a luminal agent. Large abscesses greater than 3 cm may require needle aspiration or drainage, whereas smaller abscesses usually respond to medical therapy alone.
Follow-up imaging is recommended after treatment of liver abscess to confirm resolution, which may take several months. Amebiasis carries significant morbidity and mortality in developing countries. Complications include fulminant colitis with toxic megacolon, perforation, peritonitis, formation of amebomas that mimic colon cancer, bowel obstruction, and rupture of liver abscess into pleural or pericardial spaces.
Amebiasis is a protozoal infection caused by Entamoeba histolytica. Infection may result in asymptomatic colonization, diarrhea, colitis, or invasive extra-intestinal disease, most commonly liver abscess. Although approximately 10% of the global population is estimated to be infected, symptomatic disease develops in fewer than 10% of infected individuals, and only a small proportion of those with intestinal infection progress to invasive disease.
Prevalence varies geographically, ranging from less than 5% in developed countries to 20–30% in tropical regions. In the United States, prevalence is estimated at under 4%. Infection occurs at all ages and affects both sexes equally. In endemic areas, risk factors include low socioeconomic status, poor sanitation, and overcrowding. In low-prevalence regions, infection is more common among immigrants and travelers from endemic areas, institutionalized individuals, and men who have sex with men. Severe disease is more likely in neonates, pregnant women, malnourished individuals, and those receiving corticosteroid therapy.
Humans are the only reservoir. Transmission occurs via the fecal–oral route, typically through ingestion of contaminated water or food. Chlorination does not reliably destroy cysts; boiling water is required for effective decontamination. Proper washing of vegetables with potable water or treatment with detergent and vinegar reduces risk. The organism exists in two forms: the trophozoite, which may contain ingested erythrocytes, and the quadrinucleate cyst, which is the infective form. After ingestion, excystation occurs in the small intestine, releasing trophozoites that colonize the colon. Most infected individuals remain asymptomatic cyst passers. In invasive disease, trophozoites penetrate the colonic mucosa, producing characteristic flask-shaped ulcers. Cysts can survive for months in moist environments.
Several Entamoeba species infect humans, but E. histolytica is the primary pathogenic species. Morphologically similar nonpathogenic species include Entamoeba dispar, Entamoeba moshkovskii, Entamoeba hartmanni, and Entamoeba coli.
Clinical manifestations depend on the extent of invasion. Symptoms of intestinal disease usually develop within four weeks of cyst ingestion. Asymptomatic infection is common. Noninvasive disease presents with mild diarrhea. Amebic colitis or dysentery causes crampy abdominal pain, bloody and mucoid diarrhea, rectal bleeding (especially in children), fever in about one-third of patients, weight loss, and anorexia. Extra-intestinal disease most frequently involves the liver, with abscess formation developing approximately three months after infection. Patients present with fever and right upper quadrant pain, and half may not recall prior colitis. Abscess rupture can cause peritonitis, empyema, or pleural involvement. Cerebral amebiasis is rare but presents with headache, nausea, vomiting, and altered mental status.
On examination, colitis may produce diffuse abdominal tenderness, distention, and signs of peritonitis in severe cases. Liver abscess is associated with right upper quadrant tenderness, hepatomegaly, and rarely jaundice.
Diagnosis relies on stool microscopy, antigen detection, serology, imaging, and sometimes biopsy. Stool ova and parasite examination may reveal trophozoites with ingested red blood cells. Multiple stool samples increase sensitivity. Fecal antigen detection by ELISA is more sensitive than microscopy but less sensitive than PCR. Serology is useful in invasive disease and liver abscess, though antibodies may persist for years and are less helpful in endemic regions. Leukocytosis without eosinophilia is common in invasive disease, and liver abscess may show elevated alkaline phosphatase and mild transaminase elevations. Imaging with ultrasound, CT, or MRI typically demonstrates a right-lobe liver abscess. Colonoscopy may reveal friable mucosa and flask-shaped ulcers. Aspiration of a liver abscess yields characteristic brown, odorless “anchovy paste” material, although organisms are often not recovered from the fluid itself.
Differential diagnosis includes ulcerative colitis, Crohn’s disease, colorectal carcinoma, diverticulitis, abdominal abscess, pyogenic liver abscess, hepatoma, echinococcal cyst, and irritable bowel syndrome.
Treatment depends on clinical presentation. Asymptomatic luminal infection should be treated to prevent invasive disease, typically with paromomycin for seven days, or alternatives such as diloxanide furoate or iodoquinol. Amebic colitis requires metronidazole or tinidazole followed by a luminal agent such as paromomycin or iodoquinol to eradicate cysts. Amebic liver abscess is treated with metronidazole followed by a luminal agent. Large abscesses greater than 3 cm may require needle aspiration or drainage, whereas smaller abscesses usually respond to medical therapy alone.
Follow-up imaging is recommended after treatment of liver abscess to confirm resolution, which may take several months. Amebiasis carries significant morbidity and mortality in developing countries. Complications include fulminant colitis with toxic megacolon, perforation, peritonitis, formation of amebomas that mimic colon cancer, bowel obstruction, and rupture of liver abscess into pleural or pericardial spaces.
- Published on
Emergency And Acute Medicine – Pharyngitis
Pharyngitis is inflammation or infection of the pharynx and is the third most common reason for physician visits, with approximately 30 million cases diagnosed annually. Although viral infections are the most common cause, Group A β-hemolytic Streptococcus (GAS), caused by Streptococcus pyogenes, remains the most clinically significant bacterial etiology because of potential complications. GAS is uncommon in children younger than 3 years, accounts for 20–30% of childhood pharyngitis, and 5–15% of adult cases. Incidence peaks between January and May and at the beginning of the school year, with highest rates in children aged 5–7 and 12–13 years.
Viral causes include rhinovirus, coronavirus, adenovirus, herpes simplex virus, parainfluenza, influenza, coxsackievirus, Epstein–Barr virus, and acute HIV infection. Bacterial causes include GAS, Fusobacterium necrophorum (notably associated with Lemierre disease), group C and G streptococci, Neisseria gonorrhoeae, Corynebacterium diphtheriae, Arcanobacterium haemolyticum, Mycoplasma pneumoniae, Chlamydia pneumoniae, and less commonly syphilis or tuberculosis. Noninfectious causes include Candida infection, chemical irritation, foreign bodies, inhalants, postnasal drip, malignancy, and GERD.
History helps differentiate viral from bacterial etiologies. Viral pharyngitis is often preceded by cough, rhinorrhea, and coryza. Acute HIV should be considered in at-risk patients with persistent pharyngitis. GAS typically presents with sudden-onset sore throat, fever, odynophagia, headache, abdominal pain, nausea, and vomiting. Cough, hoarseness, coryza, and diarrhea are less typical of GAS and suggest viral infection.
Physical examination must first assess for high-risk features such as stridor, respiratory distress, drooling, dysphonia, marked neck swelling, or neurologic dysfunction. Viral findings commonly include cough, rhinorrhea, and pharyngeal erythema. GAS is characterized by tonsillopharyngeal erythema with or without exudates, soft palate petechiae, a beefy red swollen uvula, tender anterior cervical lymphadenopathy, and sometimes a scarlatiniform rash. Conjunctivitis and ulcerative lesions suggest viral infection. Infectious mononucleosis may mimic GAS, presenting with exudative pharyngitis, fever, lymphadenopathy, rash, and possibly hepatosplenomegaly or jaundice. Diphtheria should be suspected in nonimmunized patients with a gray pharyngeal membrane and potential myocarditis or neuropathy. Gonococcal pharyngitis may be asymptomatic and requires consideration of sexual history and child protection concerns when appropriate.
The modified Centor (McIsaac) criteria guide testing decisions for GAS. Criteria include absence of cough, tonsillar exudates or swelling, tender anterior cervical nodes, fever >38°C, and age adjustment. Patients with low scores (<1) should not be tested or treated. those with a score of 3 undergo rapid antigen detection testing (radt), and some clinicians treat empirically when scores exceed 4. overuse empiric antibiotics without contributes to inappropriate prescribing.< />pan>
Throat culture remains the gold standard but requires 24–48 hours. RADT provides results within 30 minutes, with high specificity and good sensitivity. In children and adolescents, negative RADT results should be confirmed with culture. Proper swabbing technique is essential. Monospot testing supports diagnosis of infectious mononucleosis, though sensitivity varies by age. CBC may reveal lymphocytosis with atypical lymphocytes in mononucleosis. Imaging such as lateral neck radiographs or contrast-enhanced CT is reserved for suspected complications like epiglottitis, peritonsillar abscess, or retropharyngeal abscess.
Treatment begins with airway assessment and supportive care, including hydration and analgesia with acetaminophen or ibuprofen. GAS infection is often self-limited, but antibiotics reduce symptom duration by 1–2 days and prevent acute rheumatic fever and suppurative complications. Penicillin V or benzathine penicillin G is first-line therapy. Amoxicillin is commonly used due to palatability. Macrolides or cephalosporins are alternatives for penicillin-allergic patients. Corticosteroids may modestly improve symptom resolution when used with antibiotics but should be avoided in certain populations such as diabetics or immunocompromised patients.
Potential complications of streptococcal infection include suppurative conditions such as peritonsillar abscess, retropharyngeal abscess, otitis media, mastoiditis, and Lemierre disease. Nonsuppurative complications include acute rheumatic fever, poststreptococcal glomerulonephritis, Sydenham chorea, and reactive arthritis. PANDAS remains controversial. Diphtheria requires urgent antimicrobial therapy and airway management. Gonococcal pharyngitis is treated with ceftriaxone plus coverage for possible Chlamydia coinfection.
Patients require admission if there is airway compromise, severe dehydration, or concern for abuse. Most patients who tolerate oral intake can be discharged with appropriate follow-up. Symptoms should improve within 72 hours of appropriate therapy. Patients with GAS are no longer contagious after 24 hours of antibiotics. Individuals with mononucleosis should avoid contact sports due to splenic rupture risk. Careful use of clinical decision rules, confirmation of negative RADT in children, and vigilance for complications are essential to appropriate management.
Pharyngitis is inflammation or infection of the pharynx and is the third most common reason for physician visits, with approximately 30 million cases diagnosed annually. Although viral infections are the most common cause, Group A β-hemolytic Streptococcus (GAS), caused by Streptococcus pyogenes, remains the most clinically significant bacterial etiology because of potential complications. GAS is uncommon in children younger than 3 years, accounts for 20–30% of childhood pharyngitis, and 5–15% of adult cases. Incidence peaks between January and May and at the beginning of the school year, with highest rates in children aged 5–7 and 12–13 years.
Viral causes include rhinovirus, coronavirus, adenovirus, herpes simplex virus, parainfluenza, influenza, coxsackievirus, Epstein–Barr virus, and acute HIV infection. Bacterial causes include GAS, Fusobacterium necrophorum (notably associated with Lemierre disease), group C and G streptococci, Neisseria gonorrhoeae, Corynebacterium diphtheriae, Arcanobacterium haemolyticum, Mycoplasma pneumoniae, Chlamydia pneumoniae, and less commonly syphilis or tuberculosis. Noninfectious causes include Candida infection, chemical irritation, foreign bodies, inhalants, postnasal drip, malignancy, and GERD.
History helps differentiate viral from bacterial etiologies. Viral pharyngitis is often preceded by cough, rhinorrhea, and coryza. Acute HIV should be considered in at-risk patients with persistent pharyngitis. GAS typically presents with sudden-onset sore throat, fever, odynophagia, headache, abdominal pain, nausea, and vomiting. Cough, hoarseness, coryza, and diarrhea are less typical of GAS and suggest viral infection.
Physical examination must first assess for high-risk features such as stridor, respiratory distress, drooling, dysphonia, marked neck swelling, or neurologic dysfunction. Viral findings commonly include cough, rhinorrhea, and pharyngeal erythema. GAS is characterized by tonsillopharyngeal erythema with or without exudates, soft palate petechiae, a beefy red swollen uvula, tender anterior cervical lymphadenopathy, and sometimes a scarlatiniform rash. Conjunctivitis and ulcerative lesions suggest viral infection. Infectious mononucleosis may mimic GAS, presenting with exudative pharyngitis, fever, lymphadenopathy, rash, and possibly hepatosplenomegaly or jaundice. Diphtheria should be suspected in nonimmunized patients with a gray pharyngeal membrane and potential myocarditis or neuropathy. Gonococcal pharyngitis may be asymptomatic and requires consideration of sexual history and child protection concerns when appropriate.
The modified Centor (McIsaac) criteria guide testing decisions for GAS. Criteria include absence of cough, tonsillar exudates or swelling, tender anterior cervical nodes, fever >38°C, and age adjustment. Patients with low scores (<1) should not be tested or treated. those with a score of 3 undergo rapid antigen detection testing (radt), and some clinicians treat empirically when scores exceed 4. overuse empiric antibiotics without contributes to inappropriate prescribing.< />pan>
Throat culture remains the gold standard but requires 24–48 hours. RADT provides results within 30 minutes, with high specificity and good sensitivity. In children and adolescents, negative RADT results should be confirmed with culture. Proper swabbing technique is essential. Monospot testing supports diagnosis of infectious mononucleosis, though sensitivity varies by age. CBC may reveal lymphocytosis with atypical lymphocytes in mononucleosis. Imaging such as lateral neck radiographs or contrast-enhanced CT is reserved for suspected complications like epiglottitis, peritonsillar abscess, or retropharyngeal abscess.
Treatment begins with airway assessment and supportive care, including hydration and analgesia with acetaminophen or ibuprofen. GAS infection is often self-limited, but antibiotics reduce symptom duration by 1–2 days and prevent acute rheumatic fever and suppurative complications. Penicillin V or benzathine penicillin G is first-line therapy. Amoxicillin is commonly used due to palatability. Macrolides or cephalosporins are alternatives for penicillin-allergic patients. Corticosteroids may modestly improve symptom resolution when used with antibiotics but should be avoided in certain populations such as diabetics or immunocompromised patients.
Potential complications of streptococcal infection include suppurative conditions such as peritonsillar abscess, retropharyngeal abscess, otitis media, mastoiditis, and Lemierre disease. Nonsuppurative complications include acute rheumatic fever, poststreptococcal glomerulonephritis, Sydenham chorea, and reactive arthritis. PANDAS remains controversial. Diphtheria requires urgent antimicrobial therapy and airway management. Gonococcal pharyngitis is treated with ceftriaxone plus coverage for possible Chlamydia coinfection.
Patients require admission if there is airway compromise, severe dehydration, or concern for abuse. Most patients who tolerate oral intake can be discharged with appropriate follow-up. Symptoms should improve within 72 hours of appropriate therapy. Patients with GAS are no longer contagious after 24 hours of antibiotics. Individuals with mononucleosis should avoid contact sports due to splenic rupture risk. Careful use of clinical decision rules, confirmation of negative RADT in children, and vigilance for complications are essential to appropriate management.
- Published on
Infectious Disease and Microbiology – Bronchiolitis
Bronchiolitis is an acute inflammatory disease of the lower respiratory tract that primarily affects the terminal and respiratory bronchioles. It most commonly results from viral infection, leading to inflammatory obstruction of small airways. In some cases, inflammation may extend to adjacent alveolar ducts and alveolar spaces. Although typically viral in origin, bacterial infections can occasionally cause bronchiolitis.
Bronchiolitis is most common in infants and young children, particularly during the first two years of life, with peak incidence around 6 months of age. In the United States, the incidence has been reported as high as 11 cases per 100 children per year during the first year of life. Approximately 6 per 1,000 infants under 6 months are hospitalized annually. Each year, an estimated 675,000 ambulatory visits and 75,000 hospitalizations occur in children younger than 2 years. Bronchiolitis is the most common cause of hospitalization in infants and follows a seasonal pattern, with peak incidence during winter and early spring months.
Risk factors include male sex, age between 3 and 6 months, lack of breastfeeding, exposure to cigarette smoke, crowded living conditions, child care attendance, prematurity, low birth weight, age less than 6–12 weeks, chronic lung disease, congenital heart disease, immunodeficiency, neurological disease, congenital airway abnormalities, and high altitude. Environmental exposures such as toxic fumes, mineral dust, tobacco smoke, and certain medications (e.g., penicillamine) have also been implicated. Bone marrow, lung, and heart–lung transplantation have been associated with bronchiolitis as well.
The pathophysiology involves viral penetration of bronchiolar epithelial cells, leading to direct cellular injury and inflammation. Edema, increased mucus production, and sloughed epithelial cells obstruct small airways, resulting in air trapping and atelectasis. This obstruction contributes to wheezing, impaired gas exchange, and respiratory distress.
The most common causative agent is respiratory syncytial virus (RSV), responsible for more than 50% of cases. Other viruses include parainfluenza, influenza, rhinovirus, rubeola, mumps, parvovirus, enterovirus, coronavirus, coxsackievirus, human metapneumovirus, and varicella zoster virus. In adults, rare cases have been associated with Mycoplasma pneumoniae and Legionella pneumophila. Histologically, bronchiolitis may present as inflammatory bronchiolitis, constrictive bronchiolitis obliterans, or proliferative bronchiolitis. Otitis media is a commonly associated condition.
Clinically, bronchiolitis often begins with mild upper respiratory symptoms such as nasal congestion, coryza, and sneezing, lasting several days and sometimes accompanied by decreased appetite. Fever typically ranges between 38.5°C and 39.0°C. As the illness progresses, lower respiratory symptoms develop, including cough, expiratory wheezing, tachypnea, grunting, retractions, increased respiratory effort, and air trapping. Infants may appear in significant respiratory distress. Wheezing is common, though crackles—particularly early in inspiration—are frequently heard.
Laboratory studies are generally not diagnostic; white blood cell counts are usually normal. In severe cases, viral testing may be performed. Chest radiographs often show hyperinflation and increased anteroposterior diameter, reflecting air trapping.
The differential diagnosis includes asthma, congestive heart failure, foreign body aspiration, pertussis, organophosphate poisoning, cystic fibrosis, and bronchopneumonia. A key distinguishing feature is that bronchiolitis typically represents the first episode of wheezing in an infant, whereas asthma is characterized by recurrent wheezing.
Management is primarily supportive. Oxygen therapy, hydration, and respiratory support are the mainstays of treatment. Infants with significant respiratory distress require hospitalization and are often placed in cool, humidified oxygen. The routine use of bronchodilators is not recommended, as evidence does not support consistent clinical benefit or reduction in hospitalization. Short-term improvement in oxygen saturation or clinical scores may occur with nebulized beta-agonists in some outpatient settings, but they are not recommended for routine use. Ribavirin has been used in select high-risk patients with RSV infection, though its use remains controversial.
Most infants recover with supportive care. However, some may progress to respiratory failure requiring ventilatory support. Long-term follow-up has shown that a proportion of infants with bronchiolitis may develop hyperreactive airways later in childhood. The overall case fatality rate is less than 1%, and mortality among high-risk infants remains below 3.5%.
Bronchiolitis is an acute inflammatory disease of the lower respiratory tract that primarily affects the terminal and respiratory bronchioles. It most commonly results from viral infection, leading to inflammatory obstruction of small airways. In some cases, inflammation may extend to adjacent alveolar ducts and alveolar spaces. Although typically viral in origin, bacterial infections can occasionally cause bronchiolitis.
Bronchiolitis is most common in infants and young children, particularly during the first two years of life, with peak incidence around 6 months of age. In the United States, the incidence has been reported as high as 11 cases per 100 children per year during the first year of life. Approximately 6 per 1,000 infants under 6 months are hospitalized annually. Each year, an estimated 675,000 ambulatory visits and 75,000 hospitalizations occur in children younger than 2 years. Bronchiolitis is the most common cause of hospitalization in infants and follows a seasonal pattern, with peak incidence during winter and early spring months.
Risk factors include male sex, age between 3 and 6 months, lack of breastfeeding, exposure to cigarette smoke, crowded living conditions, child care attendance, prematurity, low birth weight, age less than 6–12 weeks, chronic lung disease, congenital heart disease, immunodeficiency, neurological disease, congenital airway abnormalities, and high altitude. Environmental exposures such as toxic fumes, mineral dust, tobacco smoke, and certain medications (e.g., penicillamine) have also been implicated. Bone marrow, lung, and heart–lung transplantation have been associated with bronchiolitis as well.
The pathophysiology involves viral penetration of bronchiolar epithelial cells, leading to direct cellular injury and inflammation. Edema, increased mucus production, and sloughed epithelial cells obstruct small airways, resulting in air trapping and atelectasis. This obstruction contributes to wheezing, impaired gas exchange, and respiratory distress.
The most common causative agent is respiratory syncytial virus (RSV), responsible for more than 50% of cases. Other viruses include parainfluenza, influenza, rhinovirus, rubeola, mumps, parvovirus, enterovirus, coronavirus, coxsackievirus, human metapneumovirus, and varicella zoster virus. In adults, rare cases have been associated with Mycoplasma pneumoniae and Legionella pneumophila. Histologically, bronchiolitis may present as inflammatory bronchiolitis, constrictive bronchiolitis obliterans, or proliferative bronchiolitis. Otitis media is a commonly associated condition.
Clinically, bronchiolitis often begins with mild upper respiratory symptoms such as nasal congestion, coryza, and sneezing, lasting several days and sometimes accompanied by decreased appetite. Fever typically ranges between 38.5°C and 39.0°C. As the illness progresses, lower respiratory symptoms develop, including cough, expiratory wheezing, tachypnea, grunting, retractions, increased respiratory effort, and air trapping. Infants may appear in significant respiratory distress. Wheezing is common, though crackles—particularly early in inspiration—are frequently heard.
Laboratory studies are generally not diagnostic; white blood cell counts are usually normal. In severe cases, viral testing may be performed. Chest radiographs often show hyperinflation and increased anteroposterior diameter, reflecting air trapping.
The differential diagnosis includes asthma, congestive heart failure, foreign body aspiration, pertussis, organophosphate poisoning, cystic fibrosis, and bronchopneumonia. A key distinguishing feature is that bronchiolitis typically represents the first episode of wheezing in an infant, whereas asthma is characterized by recurrent wheezing.
Management is primarily supportive. Oxygen therapy, hydration, and respiratory support are the mainstays of treatment. Infants with significant respiratory distress require hospitalization and are often placed in cool, humidified oxygen. The routine use of bronchodilators is not recommended, as evidence does not support consistent clinical benefit or reduction in hospitalization. Short-term improvement in oxygen saturation or clinical scores may occur with nebulized beta-agonists in some outpatient settings, but they are not recommended for routine use. Ribavirin has been used in select high-risk patients with RSV infection, though its use remains controversial.
Most infants recover with supportive care. However, some may progress to respiratory failure requiring ventilatory support. Long-term follow-up has shown that a proportion of infants with bronchiolitis may develop hyperreactive airways later in childhood. The overall case fatality rate is less than 1%, and mortality among high-risk infants remains below 3.5%.
- Published on
Infectious Disease and Microbiology – Brain Abscess
Brain abscess is a focal collection of purulent material within the brain parenchyma caused by bacterial, fungal, or protozoal infection. It may present as a well-formed abscess with a defined capsule or as an early inflammatory stage known as cerebritis. This is a rare condition, identified in 0.2–1.3% of large autopsy series and approximately 1 in 10,000 hospital admissions. About 25% of cases occur in children, and the median age at diagnosis is 30–45 years.
Risk factors include sinusitis, otitis media, poor dental hygiene, infective endocarditis, bacteremia from indwelling central lines or intravenous drug use, Osler–Weber–Rendu disease, preexisting brain injury, immunodeficiency, cyanotic congenital heart disease, and intrapulmonary shunting due to arteriovenous malformations. Preventive strategies involve prompt treatment of sinus and ear infections and maintaining good dental hygiene, particularly management of upper molar abscesses.
Infection reaches the brain through direct extension from adjacent structures (sinuses, middle ear, mastoid, orbit, teeth, meninges), following trauma or neurosurgery, or via hematogenous spread. The causative organisms often reflect the source. Otogenic, sinus, and odontogenic infections commonly involve mixed flora including anaerobes, microaerophilic and viridans streptococci, Streptococcus milleri, Haemophilus species, Fusobacterium, Prevotella, Enterobacteriaceae, and Pseudomonas. Post-traumatic or postoperative infections frequently involve Staphylococcus aureus, Pseudomonas, other gram-negative bacilli, and Propionibacterium. Hematogenous spread may involve S. aureus, streptococci, Salmonella, Listeria, Klebsiella pneumoniae, Escherichia coli, Proteus, Pseudomonas, Bacteroides species, Actinomyces, and fungi. In immunocompromised hosts, pathogens include Toxoplasma gondii, Listeria, Rhodococcus equi, Nocardia asteroides, Aspergillus, Cryptococcus neoformans, Coccidioides immitis, Candida, Zygomycetes, Cladosporium, and Curvularia. In immigrants from endemic areas, parasitic causes such as Taenia solium, Entamoeba histolytica, Schistosoma japonicum, and Paragonimus species should be considered.
Clinical manifestations are often subtle and nonspecific. Headache of less than two weeks’ duration occurs in approximately 75% of patients. Other symptoms include neck stiffness (25%), mental status changes, nausea, vomiting, low-grade fever (45–50%), focal neurological deficits (50%), and seizures (25%), which may prompt initial neuroimaging. Signs of increased intracranial pressure such as papilledema and third or sixth cranial nerve palsies suggest significant cerebral edema. Presentation varies depending on abscess location, pathogen, and underlying disease.
Laboratory findings may show leukocytosis in 60–70% of patients and elevated ESR in up to 90%. Lumbar puncture is generally contraindicated in patients with focal neurological signs due to risk of herniation. Blood cultures may be positive. Definitive microbiological diagnosis is achieved through stereotactic aspiration with Gram stain, culture, special stains, and increasingly 16S ribosomal RNA sequencing. Serologic testing may assist in suspected toxoplasmosis or neurocysticercosis.
Neuroimaging with CT or MRI is essential. Gadolinium-enhanced MRI provides superior visualization, especially in the brainstem, and diffusion-weighted imaging helps distinguish abscesses from neoplastic lesions. Ring-enhancing lesions may persist for several months despite adequate therapy. Serial imaging is necessary to monitor response to treatment.
Stereotactic aspiration is the procedure of choice for abscesses larger than 2.5 cm and that are surgically accessible. Craniotomy with aspiration may be required when vascular structures must be directly visualized. Differential diagnosis includes epidural or subdural empyema, septic dural sinus thrombosis, mycotic aneurysms, septic emboli with infarction, necrotizing encephalitis, primary or metastatic brain tumors, pyogenic meningitis, hematoma, and radiation necrosis.
Management requires prompt initiation of empiric intravenous antibiotics after appropriate cultures are obtained. For abscesses arising from oral, sinus, or otogenic sources, cefotaxime or ceftriaxone combined with metronidazole is recommended. Alternatively, penicillin G plus metronidazole may be used for oral sources. For suspected hematogenous spread, vancomycin combined with metronidazole and a third-generation cephalosporin is advised. Postsurgical infections should be treated with vancomycin plus ceftazidime or cefepime. If methicillin-sensitive S. aureus is identified, vancomycin should be replaced with nafcillin or oxacillin for improved CNS penetration. Therapy typically continues for 6–8 weeks or longer, guided by clinical and radiographic response. Corticosteroids may be used in cases of significant mass effect and depressed mental status. Surgical intervention is both diagnostic and therapeutic, relieving intracranial pressure and providing material for microbiologic diagnosis.
Complications include cerebral herniation (15–20%), persistent neurological deficits such as hemiparesis (up to 50%), epilepsy (fewer than 50%), and significant morbidity. Mortality is strongly influenced by neurological status at presentation. Long-term follow-up with serial CT or MRI scans for at least one year after completion of antibiotics is recommended to monitor for recurrence or residual disease.
Brain abscess is a focal collection of purulent material within the brain parenchyma caused by bacterial, fungal, or protozoal infection. It may present as a well-formed abscess with a defined capsule or as an early inflammatory stage known as cerebritis. This is a rare condition, identified in 0.2–1.3% of large autopsy series and approximately 1 in 10,000 hospital admissions. About 25% of cases occur in children, and the median age at diagnosis is 30–45 years.
Risk factors include sinusitis, otitis media, poor dental hygiene, infective endocarditis, bacteremia from indwelling central lines or intravenous drug use, Osler–Weber–Rendu disease, preexisting brain injury, immunodeficiency, cyanotic congenital heart disease, and intrapulmonary shunting due to arteriovenous malformations. Preventive strategies involve prompt treatment of sinus and ear infections and maintaining good dental hygiene, particularly management of upper molar abscesses.
Infection reaches the brain through direct extension from adjacent structures (sinuses, middle ear, mastoid, orbit, teeth, meninges), following trauma or neurosurgery, or via hematogenous spread. The causative organisms often reflect the source. Otogenic, sinus, and odontogenic infections commonly involve mixed flora including anaerobes, microaerophilic and viridans streptococci, Streptococcus milleri, Haemophilus species, Fusobacterium, Prevotella, Enterobacteriaceae, and Pseudomonas. Post-traumatic or postoperative infections frequently involve Staphylococcus aureus, Pseudomonas, other gram-negative bacilli, and Propionibacterium. Hematogenous spread may involve S. aureus, streptococci, Salmonella, Listeria, Klebsiella pneumoniae, Escherichia coli, Proteus, Pseudomonas, Bacteroides species, Actinomyces, and fungi. In immunocompromised hosts, pathogens include Toxoplasma gondii, Listeria, Rhodococcus equi, Nocardia asteroides, Aspergillus, Cryptococcus neoformans, Coccidioides immitis, Candida, Zygomycetes, Cladosporium, and Curvularia. In immigrants from endemic areas, parasitic causes such as Taenia solium, Entamoeba histolytica, Schistosoma japonicum, and Paragonimus species should be considered.
Clinical manifestations are often subtle and nonspecific. Headache of less than two weeks’ duration occurs in approximately 75% of patients. Other symptoms include neck stiffness (25%), mental status changes, nausea, vomiting, low-grade fever (45–50%), focal neurological deficits (50%), and seizures (25%), which may prompt initial neuroimaging. Signs of increased intracranial pressure such as papilledema and third or sixth cranial nerve palsies suggest significant cerebral edema. Presentation varies depending on abscess location, pathogen, and underlying disease.
Laboratory findings may show leukocytosis in 60–70% of patients and elevated ESR in up to 90%. Lumbar puncture is generally contraindicated in patients with focal neurological signs due to risk of herniation. Blood cultures may be positive. Definitive microbiological diagnosis is achieved through stereotactic aspiration with Gram stain, culture, special stains, and increasingly 16S ribosomal RNA sequencing. Serologic testing may assist in suspected toxoplasmosis or neurocysticercosis.
Neuroimaging with CT or MRI is essential. Gadolinium-enhanced MRI provides superior visualization, especially in the brainstem, and diffusion-weighted imaging helps distinguish abscesses from neoplastic lesions. Ring-enhancing lesions may persist for several months despite adequate therapy. Serial imaging is necessary to monitor response to treatment.
Stereotactic aspiration is the procedure of choice for abscesses larger than 2.5 cm and that are surgically accessible. Craniotomy with aspiration may be required when vascular structures must be directly visualized. Differential diagnosis includes epidural or subdural empyema, septic dural sinus thrombosis, mycotic aneurysms, septic emboli with infarction, necrotizing encephalitis, primary or metastatic brain tumors, pyogenic meningitis, hematoma, and radiation necrosis.
Management requires prompt initiation of empiric intravenous antibiotics after appropriate cultures are obtained. For abscesses arising from oral, sinus, or otogenic sources, cefotaxime or ceftriaxone combined with metronidazole is recommended. Alternatively, penicillin G plus metronidazole may be used for oral sources. For suspected hematogenous spread, vancomycin combined with metronidazole and a third-generation cephalosporin is advised. Postsurgical infections should be treated with vancomycin plus ceftazidime or cefepime. If methicillin-sensitive S. aureus is identified, vancomycin should be replaced with nafcillin or oxacillin for improved CNS penetration. Therapy typically continues for 6–8 weeks or longer, guided by clinical and radiographic response. Corticosteroids may be used in cases of significant mass effect and depressed mental status. Surgical intervention is both diagnostic and therapeutic, relieving intracranial pressure and providing material for microbiologic diagnosis.
Complications include cerebral herniation (15–20%), persistent neurological deficits such as hemiparesis (up to 50%), epilepsy (fewer than 50%), and significant morbidity. Mortality is strongly influenced by neurological status at presentation. Long-term follow-up with serial CT or MRI scans for at least one year after completion of antibiotics is recommended to monitor for recurrence or residual disease.
- Published on
Infectious Disease and Microbiology – Botulism
Botulism is a potentially life-threatening neuroparalytic syndrome caused by neurotoxins produced by Clostridium botulinum. Botulinum neurotoxin (BoNT) is among the most potent toxins known. There are five epidemiologic forms of botulism: foodborne, infant botulism, wound botulism, intestinal colonization (adult infectious botulism), and inhalational botulism. Symptoms typically develop 12–36 hours after ingestion of preformed toxin.
Botulism is rare but can occur in small outbreaks, often associated with commercially or home-canned foods. In the United States, most cases occur in infants, approximately one-fourth are foodborne, and a smaller number are related to wounds. Risk factors include improper home canning of low-acid foods such as corn, asparagus, beans, and beets. The fatality rate is higher among patients older than 60 years. Honey ingestion is a well-established risk factor for infant botulism due to gastrointestinal colonization and in situ toxin production. Wound botulism should be suspected in intravenous drug users. Iatrogenic cases have been reported following injection of unlicensed botulinum toxin preparations.
Prevention focuses on proper food preservation techniques. Home-canned foods should be boiled for at least 10 minutes before consumption. Infants under one year of age should not be given honey. Bulging cans should be discarded. Rapid identification of suspected cases is essential to prevent outbreaks.
C. botulinum is an anaerobic, gram-positive, spore-forming rod. It produces toxins classified from types A to G, based on antigenic differences. Human disease is most commonly associated with toxin types A, B, E, and F. Type A is frequently found in the western United States and China, type B in the eastern United States and Europe, and type F worldwide, often linked to fish products. The spores are widely present in soil and marine sediments. While spores are resistant to boiling, they can be destroyed by heating to 120°C. Because of its extreme toxicity, botulinum toxin is considered a potential biological warfare agent.
Clinically, botulism presents with bilateral cranial neuropathies followed by symmetric descending weakness. Patients typically remain afebrile, awake, and alert despite progressive paralysis. Sensory function remains intact. Early manifestations may include diplopia, ptosis, dysarthria, dysphagia, and dry mouth. As paralysis progresses, respiratory failure may occur. Clinical suspicion is critical, as early diagnosis significantly impacts outcomes.
Laboratory confirmation involves detection of toxin in serum, stool, or implicated food samples. The traditional mouse bioassay has limited sensitivity, particularly in wound botulism. However, treatment should not be delayed pending laboratory confirmation when clinical suspicion is high.
The differential diagnosis includes myasthenia gravis, Lambert–Eaton syndrome, tick paralysis, the Miller Fisher variant of Guillain–Barré syndrome, stroke, poliomyelitis, and heavy metal intoxication.
Management is primarily supportive, with close monitoring of respiratory function and mechanical ventilation if required. Equine-derived antitoxin covering toxin types A, B, and E should be administered as early as possible to neutralize circulating toxin. In cases of wound botulism, appropriate antibiotics should be given after antitoxin administration. In infants, intravenous human botulism immune globulin (BIG-IV) is recommended early in the course of illness. Patients often require prolonged rehabilitation. Even after recovery, some individuals may report persistent fatigue, weakness, dizziness, and respiratory difficulty.
Botulism is a potentially life-threatening neuroparalytic syndrome caused by neurotoxins produced by Clostridium botulinum. Botulinum neurotoxin (BoNT) is among the most potent toxins known. There are five epidemiologic forms of botulism: foodborne, infant botulism, wound botulism, intestinal colonization (adult infectious botulism), and inhalational botulism. Symptoms typically develop 12–36 hours after ingestion of preformed toxin.
Botulism is rare but can occur in small outbreaks, often associated with commercially or home-canned foods. In the United States, most cases occur in infants, approximately one-fourth are foodborne, and a smaller number are related to wounds. Risk factors include improper home canning of low-acid foods such as corn, asparagus, beans, and beets. The fatality rate is higher among patients older than 60 years. Honey ingestion is a well-established risk factor for infant botulism due to gastrointestinal colonization and in situ toxin production. Wound botulism should be suspected in intravenous drug users. Iatrogenic cases have been reported following injection of unlicensed botulinum toxin preparations.
Prevention focuses on proper food preservation techniques. Home-canned foods should be boiled for at least 10 minutes before consumption. Infants under one year of age should not be given honey. Bulging cans should be discarded. Rapid identification of suspected cases is essential to prevent outbreaks.
C. botulinum is an anaerobic, gram-positive, spore-forming rod. It produces toxins classified from types A to G, based on antigenic differences. Human disease is most commonly associated with toxin types A, B, E, and F. Type A is frequently found in the western United States and China, type B in the eastern United States and Europe, and type F worldwide, often linked to fish products. The spores are widely present in soil and marine sediments. While spores are resistant to boiling, they can be destroyed by heating to 120°C. Because of its extreme toxicity, botulinum toxin is considered a potential biological warfare agent.
Clinically, botulism presents with bilateral cranial neuropathies followed by symmetric descending weakness. Patients typically remain afebrile, awake, and alert despite progressive paralysis. Sensory function remains intact. Early manifestations may include diplopia, ptosis, dysarthria, dysphagia, and dry mouth. As paralysis progresses, respiratory failure may occur. Clinical suspicion is critical, as early diagnosis significantly impacts outcomes.
Laboratory confirmation involves detection of toxin in serum, stool, or implicated food samples. The traditional mouse bioassay has limited sensitivity, particularly in wound botulism. However, treatment should not be delayed pending laboratory confirmation when clinical suspicion is high.
The differential diagnosis includes myasthenia gravis, Lambert–Eaton syndrome, tick paralysis, the Miller Fisher variant of Guillain–Barré syndrome, stroke, poliomyelitis, and heavy metal intoxication.
Management is primarily supportive, with close monitoring of respiratory function and mechanical ventilation if required. Equine-derived antitoxin covering toxin types A, B, and E should be administered as early as possible to neutralize circulating toxin. In cases of wound botulism, appropriate antibiotics should be given after antitoxin administration. In infants, intravenous human botulism immune globulin (BIG-IV) is recommended early in the course of illness. Patients often require prolonged rehabilitation. Even after recovery, some individuals may report persistent fatigue, weakness, dizziness, and respiratory difficulty.
- Published on
Infectious Disease and Microbiology – Blepharitis and Chalazion
Blepharitis is an infection and inflammation of the eyelid margins. It may be classified as anterior (involving inflammation at the base of the eyelashes), posterior (affecting the inner portion of the eyelid and meibomian glands), or granulomatous. Chalazion, in contrast, is a painless granulomatous inflammation of a meibomian gland that produces a localized nodule within the eyelid. Blepharitis is a common condition encountered by both primary care physicians and ophthalmologists. Posterior blepharitis is frequently associated with rosacea and seborrheic dermatitis.
Risk factors include dermatologic conditions such as atopic dermatitis, with more than three-fourths of such patients demonstrating positive cultures for Staphylococcus aureus. However, a positive culture does not always indicate active infection, and clinical correlation is essential. The pathophysiology involves bacterial colonization and inflammation that alter meibomian gland secretions, contributing to gland dysfunction and chronic irritation.
The most common causative organisms are Staphylococcus species, particularly S. aureus. Numerous other pathogens have been reported, including bacteria, fungi, viruses, and parasites, although these are less common. Organisms capable of colonizing adjacent skin areas such as the scalp or nares may spread to the eyelids and contribute to infection. Blepharitis is commonly associated with rosacea and seborrheic dermatitis.
Patients typically report chronic irritation, burning sensation, mild redness, and occasional pruritus of the eyelids. Some may experience blurred vision. On physical examination, acute blepharitis may present with collections of pus and ulceration at the lid margin. Chronic blepharitis often shows misdirected or missing eyelashes, telangiectasia, and a swollen lid margin. Superficial lid involvement usually presents with hyperemia and telangiectasia. Slit-lamp examination by an ophthalmologist may assist in evaluation.
Management focuses primarily on conservative measures. Warm compresses and strict eyelid hygiene are foundational treatments. Gentle massage of the eyelids using a diluted mixture of baby shampoo and water applied with a cotton-tipped applicator helps improve meibomian gland drainage. Topical ophthalmic antibiotics such as bacitracin or erythromycin (twice to four times daily for approximately two weeks) are commonly used for staphylococcal blepharitis. Gentamicin and 1% mercuric oxide preparations may also be used. In chronic or refractory cases, cultures should be obtained, and systemic antibiotics such as dicloxacillin, quinolones, or azithromycin may be considered.
For chalazion, persistent and nontender lesions may require incision and curettage. This involves removal of inflammatory debris via conjunctival incision. If infection is absent, intralesional corticosteroid injection may be considered. In rare cases of necrotizing fasciitis involving the eyelids, urgent surgical debridement is required.
Follow-up is important for nonhealing or ulcerative eyelid lesions, as basal cell carcinoma, squamous cell carcinoma, or meibomian gland carcinoma must be excluded. Complications include the development of hordeolum (stye). An external hordeolum results from staphylococcal infection of the glands of Zeis or Moll at the eyelid margin, whereas an internal hordeolum involves suppurative infection of the meibomian glands within the tarsal plate.
Blepharitis is an infection and inflammation of the eyelid margins. It may be classified as anterior (involving inflammation at the base of the eyelashes), posterior (affecting the inner portion of the eyelid and meibomian glands), or granulomatous. Chalazion, in contrast, is a painless granulomatous inflammation of a meibomian gland that produces a localized nodule within the eyelid. Blepharitis is a common condition encountered by both primary care physicians and ophthalmologists. Posterior blepharitis is frequently associated with rosacea and seborrheic dermatitis.
Risk factors include dermatologic conditions such as atopic dermatitis, with more than three-fourths of such patients demonstrating positive cultures for Staphylococcus aureus. However, a positive culture does not always indicate active infection, and clinical correlation is essential. The pathophysiology involves bacterial colonization and inflammation that alter meibomian gland secretions, contributing to gland dysfunction and chronic irritation.
The most common causative organisms are Staphylococcus species, particularly S. aureus. Numerous other pathogens have been reported, including bacteria, fungi, viruses, and parasites, although these are less common. Organisms capable of colonizing adjacent skin areas such as the scalp or nares may spread to the eyelids and contribute to infection. Blepharitis is commonly associated with rosacea and seborrheic dermatitis.
Patients typically report chronic irritation, burning sensation, mild redness, and occasional pruritus of the eyelids. Some may experience blurred vision. On physical examination, acute blepharitis may present with collections of pus and ulceration at the lid margin. Chronic blepharitis often shows misdirected or missing eyelashes, telangiectasia, and a swollen lid margin. Superficial lid involvement usually presents with hyperemia and telangiectasia. Slit-lamp examination by an ophthalmologist may assist in evaluation.
Management focuses primarily on conservative measures. Warm compresses and strict eyelid hygiene are foundational treatments. Gentle massage of the eyelids using a diluted mixture of baby shampoo and water applied with a cotton-tipped applicator helps improve meibomian gland drainage. Topical ophthalmic antibiotics such as bacitracin or erythromycin (twice to four times daily for approximately two weeks) are commonly used for staphylococcal blepharitis. Gentamicin and 1% mercuric oxide preparations may also be used. In chronic or refractory cases, cultures should be obtained, and systemic antibiotics such as dicloxacillin, quinolones, or azithromycin may be considered.
For chalazion, persistent and nontender lesions may require incision and curettage. This involves removal of inflammatory debris via conjunctival incision. If infection is absent, intralesional corticosteroid injection may be considered. In rare cases of necrotizing fasciitis involving the eyelids, urgent surgical debridement is required.
Follow-up is important for nonhealing or ulcerative eyelid lesions, as basal cell carcinoma, squamous cell carcinoma, or meibomian gland carcinoma must be excluded. Complications include the development of hordeolum (stye). An external hordeolum results from staphylococcal infection of the glands of Zeis or Moll at the eyelid margin, whereas an internal hordeolum involves suppurative infection of the meibomian glands within the tarsal plate.
- Published on
Infectious Disease and Microbiology – Blastomycosis
Blastomycosis is an acute or chronic infection caused by Blastomyces dermatitidis, a dimorphic fungus found in soil. The organism exists as mold in the environment and converts to yeast in human tissue. The annual incidence ranges from 0.3 to 1.8 cases per 100,000 population, with up to 7.4 hospital admissions per 1 million people in endemic regions. The infection is endemic in areas near bodies of water in the southeastern United States and along the Mississippi, Ohio, and St. Lawrence River valleys. It is also found along the Mediterranean coast, in South America, Mexico, and parts of Africa. Although previously thought to affect middle-aged men more commonly, this is likely related to environmental exposure patterns rather than gender predisposition. Immunocompromised individuals are at risk for more severe disease and poorer outcomes. Prevention focuses on minimizing exposure in endemic regions, including the use of respiratory protection for individuals at occupational risk.
Infection occurs through inhalation of conidia from the environment, with potential for hematogenous dissemination to other organs. The immune system more effectively clears the conidial form; however, once inside the host, the organism converts into a broad-based budding yeast form that is less susceptible to immune clearance. Reactivation may occur in immunocompromised patients.
Clinically, blastomycosis most commonly presents as pulmonary disease. Acute pneumonia presents with fever, night sweats, productive cough, dyspnea, and pleuritic chest pain, and may be accompanied by rash. Chronic pneumonia resembles pulmonary tuberculosis, with subacute onset of fever, night sweats, weight loss, mild productive cough, and sometimes hemoptysis. Disseminated disease can involve the skin, bones, genitourinary tract, central nervous system, or other organs. Skin lesions are typically non-tender papules, nodules, or plaques that may become verrucous or ulcerated. Soft tissue swelling may occur and can form draining tracts. CNS involvement may manifest as meningitis or focal neurologic deficits.
Diagnosis relies primarily on culture and direct visualization. Serologic testing is limited due to cross-reactivity with other endemic mycoses. Urine antigen testing is available but also limited by cross-reactivity. Chest radiography may reveal masses, nodules, lobar infiltrates, or cavitary lesions; lymphadenopathy is uncommon. Culture is positive in approximately 86% of sputum samples and 92% of bronchoalveolar lavage specimens. Wet mount preparations using potassium hydroxide or calcofluor white have about 46% sensitivity. The characteristic finding is a large yeast (8–15 μm) with a single broad-based bud. Histopathology shows pyogranulomas, and fungal elements are more easily visualized with methenamine silver or periodic acid–Schiff stains. The differential diagnosis includes atypical pneumonia, lung cancer, mycobacterial disease, and squamous cell carcinoma for cutaneous lesions.
Treatment depends on severity and organ involvement. For pulmonary or disseminated non-CNS disease, amphotericin B (or a lipid/liposomal formulation) is administered for two weeks, followed by itraconazole 200 mg three times daily for three days, then 200 mg twice daily for 6–12 months. Mild to moderate disease may be treated with itraconazole alone for 6–12 months. CNS disease requires lipid/liposomal amphotericin B (3–5 mg/kg IV for 4–6 weeks), followed by at least 12 months of oral azole therapy (itraconazole, fluconazole, or voriconazole). Immunocompromised patients should receive amphotericin B followed by itraconazole for at least 12 months, and lifelong suppressive therapy may be considered. In children with mild disease, itraconazole (10 mg/kg/day) is recommended for 6–12 months; severe disease requires amphotericin followed by itraconazole. In pregnancy, amphotericin B is the treatment of choice, as azoles are contraindicated.
Patients require close monitoring for antifungal toxicity. Therapeutic drug monitoring of itraconazole is recommended after two weeks of therapy, with target levels greater than 1.0 μg/mL and less than 10 μg/mL. Liver function tests should be monitored at least every three months during azole therapy. Itraconazole should be taken with food to enhance absorption. Follow-up for approximately six months after completion of therapy is recommended due to relapse risk.
Prognosis is favorable in immunocompetent individuals, with cure rates of 90–97% when treated appropriately with amphotericin. Mortality approaches 40% in immunocompromised patients, particularly those with bone marrow transplantation or AIDS. Outcomes in pregnant women can be excellent if diagnosed early, though they are at increased risk for severe disease. Complications include respiratory failure (acute respiratory distress syndrome), CNS involvement, and relapse.
Blastomycosis is an acute or chronic infection caused by Blastomyces dermatitidis, a dimorphic fungus found in soil. The organism exists as mold in the environment and converts to yeast in human tissue. The annual incidence ranges from 0.3 to 1.8 cases per 100,000 population, with up to 7.4 hospital admissions per 1 million people in endemic regions. The infection is endemic in areas near bodies of water in the southeastern United States and along the Mississippi, Ohio, and St. Lawrence River valleys. It is also found along the Mediterranean coast, in South America, Mexico, and parts of Africa. Although previously thought to affect middle-aged men more commonly, this is likely related to environmental exposure patterns rather than gender predisposition. Immunocompromised individuals are at risk for more severe disease and poorer outcomes. Prevention focuses on minimizing exposure in endemic regions, including the use of respiratory protection for individuals at occupational risk.
Infection occurs through inhalation of conidia from the environment, with potential for hematogenous dissemination to other organs. The immune system more effectively clears the conidial form; however, once inside the host, the organism converts into a broad-based budding yeast form that is less susceptible to immune clearance. Reactivation may occur in immunocompromised patients.
Clinically, blastomycosis most commonly presents as pulmonary disease. Acute pneumonia presents with fever, night sweats, productive cough, dyspnea, and pleuritic chest pain, and may be accompanied by rash. Chronic pneumonia resembles pulmonary tuberculosis, with subacute onset of fever, night sweats, weight loss, mild productive cough, and sometimes hemoptysis. Disseminated disease can involve the skin, bones, genitourinary tract, central nervous system, or other organs. Skin lesions are typically non-tender papules, nodules, or plaques that may become verrucous or ulcerated. Soft tissue swelling may occur and can form draining tracts. CNS involvement may manifest as meningitis or focal neurologic deficits.
Diagnosis relies primarily on culture and direct visualization. Serologic testing is limited due to cross-reactivity with other endemic mycoses. Urine antigen testing is available but also limited by cross-reactivity. Chest radiography may reveal masses, nodules, lobar infiltrates, or cavitary lesions; lymphadenopathy is uncommon. Culture is positive in approximately 86% of sputum samples and 92% of bronchoalveolar lavage specimens. Wet mount preparations using potassium hydroxide or calcofluor white have about 46% sensitivity. The characteristic finding is a large yeast (8–15 μm) with a single broad-based bud. Histopathology shows pyogranulomas, and fungal elements are more easily visualized with methenamine silver or periodic acid–Schiff stains. The differential diagnosis includes atypical pneumonia, lung cancer, mycobacterial disease, and squamous cell carcinoma for cutaneous lesions.
Treatment depends on severity and organ involvement. For pulmonary or disseminated non-CNS disease, amphotericin B (or a lipid/liposomal formulation) is administered for two weeks, followed by itraconazole 200 mg three times daily for three days, then 200 mg twice daily for 6–12 months. Mild to moderate disease may be treated with itraconazole alone for 6–12 months. CNS disease requires lipid/liposomal amphotericin B (3–5 mg/kg IV for 4–6 weeks), followed by at least 12 months of oral azole therapy (itraconazole, fluconazole, or voriconazole). Immunocompromised patients should receive amphotericin B followed by itraconazole for at least 12 months, and lifelong suppressive therapy may be considered. In children with mild disease, itraconazole (10 mg/kg/day) is recommended for 6–12 months; severe disease requires amphotericin followed by itraconazole. In pregnancy, amphotericin B is the treatment of choice, as azoles are contraindicated.
Patients require close monitoring for antifungal toxicity. Therapeutic drug monitoring of itraconazole is recommended after two weeks of therapy, with target levels greater than 1.0 μg/mL and less than 10 μg/mL. Liver function tests should be monitored at least every three months during azole therapy. Itraconazole should be taken with food to enhance absorption. Follow-up for approximately six months after completion of therapy is recommended due to relapse risk.
Prognosis is favorable in immunocompetent individuals, with cure rates of 90–97% when treated appropriately with amphotericin. Mortality approaches 40% in immunocompromised patients, particularly those with bone marrow transplantation or AIDS. Outcomes in pregnant women can be excellent if diagnosed early, though they are at increased risk for severe disease. Complications include respiratory failure (acute respiratory distress syndrome), CNS involvement, and relapse.
- Published on
Infectious Disease and Microbiology – Bell’s Palsy
Bell’s palsy is defined as an acute, idiopathic, unilateral paralysis of the facial nerve (cranial nerve VII). Approximately half of all facial nerve palsies are classified as Bell’s palsy. Bilateral involvement is rare, occurring in about 0.3% of cases. Although termed “idiopathic,” viral etiologies are strongly suspected, particularly herpes simplex virus. Other infectious associations include herpes zoster (including herpes zoster oticus). Rarely, Bell’s palsy has been reported as an adverse event following immunization.
The incidence in the United States ranges from 13 to 34 cases per 100,000 persons annually. The condition most commonly affects individuals aged 20–35 years and those over 70 years of age. Males and females are equally affected. Bell’s palsy is the most common cause of seventh nerve palsy in children. Risk factors include pregnancy, diabetes mellitus, and hypertension in individuals older than 40 years. Currently, there is no known preventive measure.
Clinically, Bell’s palsy presents with acute onset over one to two days and rapid progression to partial or complete unilateral facial paralysis. Patients may experience decreased tear and saliva production on the affected side, hyperacusis (increased sensitivity to sound), dysgeusia (altered taste), and retroauricular pain. The diagnosis is primarily clinical.
The differential diagnosis is broad and includes infectious causes such as Lyme disease, HIV infection (particularly during seroconversion), otitis media, mastoiditis, tuberculosis, syphilis, infectious meningitis, rubella, tetanus, Mycoplasma infection, and enteroviral infections. Noninfectious causes include sarcoidosis, Sjögren’s syndrome, systemic lupus erythematosus, tumors (parotid gland tumors, melanoma, meningioma), cerebral aneurysm, Guillain-Barré syndrome, trauma, iatrogenic injury, and others. In cases of bilateral facial paralysis, Lyme disease and sarcoidosis should be strongly considered.
Electrodiagnostic studies such as electromyography (EMG) or electroneurography may be useful in selected cases, particularly if recovery is incomplete. Patients with a typical presentation and early recovery usually do not require further testing. Imaging with CT or MRI is indicated if the presentation is atypical, if symptoms progress slowly, or if there is no improvement within six months, to exclude intracranial or middle ear pathology. Recent evidence suggests that ultrasound measurement of the distal facial nerve diameter may help predict recovery at three months.
Early treatment significantly improves outcomes. Prednisolone should be initiated within three days of symptom onset, at a dose of 60–80 mg daily for one week, as it increases the likelihood of complete recovery at three and nine months. Antiviral therapy may be added in severe cases of facial palsy. Eye protection is essential, including artificial tears during the day and lubricating ointment at night, to prevent corneal injury. The role of surgical decompression remains controversial.
Ongoing care focuses on eye protection and psychological support. Complications include incomplete recovery in approximately one-third of patients, keratitis, corneal abrasions, and recurrence in 7–15% of cases.
Bell’s palsy is defined as an acute, idiopathic, unilateral paralysis of the facial nerve (cranial nerve VII). Approximately half of all facial nerve palsies are classified as Bell’s palsy. Bilateral involvement is rare, occurring in about 0.3% of cases. Although termed “idiopathic,” viral etiologies are strongly suspected, particularly herpes simplex virus. Other infectious associations include herpes zoster (including herpes zoster oticus). Rarely, Bell’s palsy has been reported as an adverse event following immunization.
The incidence in the United States ranges from 13 to 34 cases per 100,000 persons annually. The condition most commonly affects individuals aged 20–35 years and those over 70 years of age. Males and females are equally affected. Bell’s palsy is the most common cause of seventh nerve palsy in children. Risk factors include pregnancy, diabetes mellitus, and hypertension in individuals older than 40 years. Currently, there is no known preventive measure.
Clinically, Bell’s palsy presents with acute onset over one to two days and rapid progression to partial or complete unilateral facial paralysis. Patients may experience decreased tear and saliva production on the affected side, hyperacusis (increased sensitivity to sound), dysgeusia (altered taste), and retroauricular pain. The diagnosis is primarily clinical.
The differential diagnosis is broad and includes infectious causes such as Lyme disease, HIV infection (particularly during seroconversion), otitis media, mastoiditis, tuberculosis, syphilis, infectious meningitis, rubella, tetanus, Mycoplasma infection, and enteroviral infections. Noninfectious causes include sarcoidosis, Sjögren’s syndrome, systemic lupus erythematosus, tumors (parotid gland tumors, melanoma, meningioma), cerebral aneurysm, Guillain-Barré syndrome, trauma, iatrogenic injury, and others. In cases of bilateral facial paralysis, Lyme disease and sarcoidosis should be strongly considered.
Electrodiagnostic studies such as electromyography (EMG) or electroneurography may be useful in selected cases, particularly if recovery is incomplete. Patients with a typical presentation and early recovery usually do not require further testing. Imaging with CT or MRI is indicated if the presentation is atypical, if symptoms progress slowly, or if there is no improvement within six months, to exclude intracranial or middle ear pathology. Recent evidence suggests that ultrasound measurement of the distal facial nerve diameter may help predict recovery at three months.
Early treatment significantly improves outcomes. Prednisolone should be initiated within three days of symptom onset, at a dose of 60–80 mg daily for one week, as it increases the likelihood of complete recovery at three and nine months. Antiviral therapy may be added in severe cases of facial palsy. Eye protection is essential, including artificial tears during the day and lubricating ointment at night, to prevent corneal injury. The role of surgical decompression remains controversial.
Ongoing care focuses on eye protection and psychological support. Complications include incomplete recovery in approximately one-third of patients, keratitis, corneal abrasions, and recurrence in 7–15% of cases.
